Showing results (161-170 of 176) with videos related to
Sort By:
Pageof 18
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC: A Multicenter Retrospective StudySarah Waliany, Shambo Guha Roy, Federica Pecci, et al.Cancer Discovery|January 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody TarlatamabAvanish Mishra, Catherine B Meador, Kruthika Kikkeri, et al.The Lancet. Oncology|September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisAlice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinomaTheodore S Hong, David P Ryan, Darrell R Borger, et al.Cancer Discovery|August 17, 2019
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F Farago, Beow Y Yeap, Marcello Stanzione, et al.Journal of the National Cancer Institute|September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor GenotypeTheodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.Cancer Research|November 12, 2015
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural MesotheliomaAssunta De Rienzo, Michael A Archer, Beow Y Yeap, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion-Positive Lung CancerJessica J Lin, Noura J Choudhury, Satoshi Yoda, et al.Pageof 18